Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

IQV vs VEEV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

VEEV Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 5–4 Matrix Metrics)

VEEV Overall Winner 6-Pillar Tally: IQV 1 – 5 VEEV Matrix Metrics: IQV 4 – 5 VEEV

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over IQVIA Holdings Inc. (IQV) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IQV carries a Unified Composite Score of 60.2/100 (BUY) at $258.94 (18.6x Forward P/E, 13.9% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin).

  • Composite vs. Pillar Nuance: While IQV currently prints a higher short-term Unified Composite Score (60.2/100 BUY vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 13.9% operating margin) and revenue trajectory (+17.6% vs. +8.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IQV vs VEEV
IQV NYSE
IQVIA Holdings Inc.
Services-Commercial Physical & Biological Research
$258.94
-2.19% 1D
Market Cap $43.7B
TTM Revenue $17.3B
Forward P/E 18.6x
Beta / 30D Vol 0.39β · 30% Vol
Unified Composite Score
60.2 / 100 BUY
Tech 50.0 Fund 52.0 Flow 58.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 41.3 · SMA20: $270.54 · SMA50: $267.35
VEEV NYSE Head-to-Head Winner
Veeva Systems Inc.
Services-Prepackaged Software
$290.25
-3.02% 1D
Market Cap $48.8B
TTM Revenue $3.46B
Forward P/E 34.8x
Beta / 30D Vol 0.39β · 20% Vol
Unified Composite Score
48.5 / 100 HOLD
Tech 45.0 Fund 53.0 Flow 68.0 Mom 46.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.9 · SMA20: $309.35 · SMA50: $292.48

6-Pillar Scorecard Institutional Category Breakdown (IQV 1 – 5 VEEV)

Columns: Metric · IQV · VEEV
1. Valuation Multiples IQV
Forward P/E 18.6x 34.8x
Trailing P/E 32.2x 49.4x
PEG Ratio 0.98x 1.16x
EV / Revenue 3.3x 13.6x
2. Growth & Scale VEEV
Revenue Growth (YoY) +8.0% +17.6%
Earnings Growth (YoY) +8.8% +39.5%
TTM Revenue (USD) $17.3B $3.46B
Market Cap $43.7B $48.8B
3. Profitability & Quality VEEV
Gross Margin 33.1% 75.0%
Operating Margin 13.9% 29.9%
Net Profit Margin 8.1% 29.3%
Return on Equity (ROE) 21.4% 14.4%
4. Balance Sheet & Cash Flow VEEV
Cash Generation (TTM) $2.08B $1.67B
Cash Flow Margin 12.0% 48.2%
Net Cash / Leverage $14.1B Net Debt (2.45x D/E) $1.66B Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VEEV
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 36.5% (3rd %ile) 45.0% (55th %ile)
Put/Call OI Skew 0.60x (Call-Skewed) 0.71x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat VEEV
OpEx & R&D Intensity 19.2% of Rev ($3.32B) 45.1% of Rev ($1.56B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Diagnostics & Research Operator Health Information Services Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IQV (4) vs VEEV (5)
Institutional Metric IQV VEEV Criterion Row Edge
Market Capitalization
Scale
$43.7B $48.8B Larger Scale VEEV
Trailing P/E Ratio
Valuation
32.2x 49.4x Lower Multiple IQV
Forward P/E Ratio
Valuation
18.6x 34.8x Lower Multiple IQV
Revenue Growth (YoY)
Growth
+8.0% +17.6% Higher Growth VEEV
Operating Margin (TTM)
Profitability
13.9% 29.9% Higher Margin VEEV
Net Profit Margin
Profitability
8.1% 29.3% Higher Margin VEEV
Return on Equity (ROE)
Capital Efficiency
21.4% 14.4% Higher ROE IQV
52-Week Range Position
Momentum
80% ($154–$284) 80% ($148–$326) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
0.39β · 30% Vol 0.39β · 20% Vol Lower Realized Risk VEEV
Unified Institutional Score
Composite Signal
60.2 / 100 (BUY) 48.5 / 100 (HOLD) Higher Composite IQV
Trailing 12M Revenue (USD)
Operating Scale
$17.3B $3.46B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
33.1% 75.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.98x PEG · 3.3x EV/Rev 1.16x PEG · 13.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$2.08B ($14.1B Net Debt (2.45x D/E)) $1.67B ($1.66B Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IQV +5.77 pp
IQV: -2.61% · VEEV: -8.38%
3M Horizon VEEV +11.76 pp
IQV: +3.88% · VEEV: +15.64%
6M Horizon VEEV +28.21 pp
IQV: +49.52% · VEEV: +77.73%
1Y Horizon IQV +18.44 pp
IQV: +17.38% · VEEV: -1.06%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period IQV Revenue VEEV Revenue IQV Op. Margin VEEV Op. Margin Margin Leader
FY2019 $11.1B $860M 7.0% 25.8% VEEV
FY2020 $11.4B $1.10B 6.4% 25.9% VEEV
FY2021 $13.9B $1.47B 10.0% 25.8% VEEV
FY2022 $14.4B $1.85B 12.5% 27.3% VEEV
FY2023 $15.0B $2.16B 13.2% 21.3% VEEV
FY2024 $15.4B $2.36B 14.3% 18.2% VEEV
FY2025 $16.3B $2.75B 13.4% 25.2% VEEV
FY2026 N/A $3.20B N/A 28.7% VEEV

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IQV CONSOLIDATION
52d in phase · OBV DISTRIBUTION
Current IV 36.5%
IV Percentile 3rd %ile
Put/Call OI Skew 0.60x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact IQV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VEEV CONSOLIDATION
55d in phase · OBV DISTRIBUTION
Current IV 45.0%
IV Percentile 55th %ile
Put/Call OI Skew 0.71x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact VEEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $262.06 · IV 39.1%

IQV vs. VEEV: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of IQV ($26,206) vs. VEEV ($29,928) against risk-defined 5-day vertical and put-wall option structures.

IQV Spot $262.06 · IV 39.1%
IQV Options Simulator →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $250 / $240 Bull Put Spread

Sell 1x $250P · Buy 1x $240P · 31d

Net Entry $300 Credit
Max Credit / Yield +$300 (+42.9% RoM)
Max Risk / Buffer -5.7% Cushion ($700 Mgn)
5d Edge & Liquidity 70% PoP · Liq B
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq B

Dec 18 $260 / $250 Bear Put Spread

Buy 1x $260P · Sell 1x $250P · 31d

Net Entry $430 Debit
T+5d @ -5% Drop +$188 (+44%)
Max Risk / Buffer $430 Capped
5d Edge & Liquidity 0.9x R:R · Liq B
Simulate 5-Day Payoff →
VEEV Spot $299.28 · IV 50.8%
VEEV Options Simulator →
5-DAY BULLISH SWING Liq B

Dec 18 $300 / $330 Bull Call Spread

Buy 1x $300C · Sell 1x $330C · 32d

Net Entry $1,140 Debit
T+5d @ +5% Move +$352 (+31%)
Max Risk / Buffer $1,140 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $280 / $260 Bull Put Spread

Sell 1x $280P · Buy 1x $260P · 32d

Net Entry $478 Credit
Max Credit / Yield +$478 (+31.4% RoM)
Max Risk / Buffer -8.0% Cushion ($1,522 Mgn)
5d Edge & Liquidity 71% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IQV Moat Profile Scale & Operating Efficiency Moat
Diagnostics & Research Operator
Competes within the Diagnostics & Research value chain with $43.7B market capitalization and 13.9% operating margin.
OpEx & R&D Reinvestment 19.2% of Rev ($3.32B)
90D Engineering Disclosures 0 Published
VEEV Moat Profile Scale & Operating Efficiency Moat
Health Information Services Operator
Competes within the Health Information Services value chain with $48.8B market capitalization and 29.9% operating margin.
OpEx & R&D Reinvestment 45.1% of Rev ($1.56B)
90D Engineering Disclosures 0 Published

Investor FAQ IQV vs VEEV Key Questions & Quantitative Answers

As of Nov 17, 2026, Veeva Systems Inc. (VEEV) is the stronger overall head-to-head candidate over IQVIA Holdings Inc. (IQV) in the Tradestie Institutional Equity Comparison Engine, winning 5–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). IQV carries a Unified Composite Score of 60.2/100 (BUY) at $258.94 (18.6x Forward P/E, 13.9% operating margin), whereas VEEV carries 48.5/100 (HOLD) at $290.25 (34.8x Forward P/E, 29.9% operating margin). Composite vs. Pillar Nuance: While IQV currently prints a higher short-term Unified Composite Score (60.2/100 BUY vs. VEEV 48.5/100 HOLD), VEEV captures the overall institutional head-to-head verdict (5–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (29.9% vs. 13.9% operating margin) and revenue trajectory (+17.6% vs. +8.0% YoY).

VEEV leads the Growth & Scale pillar: IQV posts +8.0% YoY revenue growth and +8.8% YoY earnings growth on $17.3B TTM revenue (33.1% gross margin, 13.9% operating margin), compared with VEEV at +17.6% YoY revenue growth and +39.5% YoY earnings growth on $3.46B TTM revenue (75.0% gross margin, 29.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), IQV cumulative revenue shifted +47.1% while VEEV shifted +272.1%. In operating R&D and SG&A reinvestment, IQV deploys 19.2% of Rev ($3.32B) (0 90-day corporate R&D disclosures) versus 45.1% of Rev ($1.56B) (0 disclosures) for VEEV.

IQV screens cheaper on headline valuation multiples. IQV trades at 18.6x Forward P/E, 32.2x Trailing P/E, 0.98x PEG, and 3.3x EV/Revenue (12.0% FCF margin), whereas VEEV trades at 34.8x Forward P/E, 49.4x Trailing P/E, 1.16x PEG, and 13.6x EV/Revenue (48.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IQV (21.4% ROE) versus VEEV (14.4% ROE) capital efficiency.

In options market volatility and institutional positioning, IQV carries 36.5% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.60x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 30% Vol realized risk). By comparison, VEEV carries 45.0% implied volatility (55th %ile, Balanced (25th–60th %ile)), a 0.71x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.39β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.